“Impact of Infections in Patients with Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax during Induction Chemotherapy” (2025) Indus Journal of Bioscience Research, 3(1), pp. 190–196. doi:10.70749/ijbr.v3i1.469.